• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bicycle Therapeutics Plc ADR (NQ: BCYC )

    22.70 +0.36 (+1.61%)
    Streaming Delayed Price Updated: 11:14 AM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 36,743
    Open 22.42
    Bid (Size) 22.67 (1)
    Ask (Size) 22.73 (2)
    Prev. Close 22.34
    Today's Range 22.02 - 22.77
    52wk Range 12.54 - 27.24
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    The Latest Analyst Ratings For Bicycle Therapeutics
    Via Benzinga

    Performance

    YTD
    +23.10%
    +23.10%
    1 Month
    -4.46%
    -4.46%
    3 Month
    -3.32%
    -3.32%
    6 Month
    -5.34%
    -5.34%
    1 Year
    -0.61%
    -0.61%

    More News

    Read More
    BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    Expert Ratings For Bicycle Therapeutics
    Via Benzinga
    The Analyst Landscape: 4 Takes On Bicycle Therapeutics
    Via Benzinga
    Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views
    Via Benzinga
    Topics Earnings Stocks
    Exposures Financial US Equities
    Gold Falls Sharply; US Composite PMI Surges In May
    Via Benzinga
    e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
    From Bicycle Therapeutics plc
    Via Business Wire
    BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
    From Bicycle Therapeutics plc
    Via Business Wire
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.